The FDA has cleared the research organization's investigational new drug application, allowing it to start clinical tests of the experimental treatment DT2-SCT.
As drugmakers take lessons from oncology in developing CAR T cells for other diseases, they must contend with risks that ...
The bill would establish the right of cancer patients to access advanced care, including precision medicine and genomic testing, in their communities.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback